These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5574957)

  • 1. [Treatment of juvenile rheumatoid arthritis with chloroquine phosphate and hydroxychloroquine sulphate. Dosage of syrup and tablets with determinations of serum concentrations].
    Laaksonen AL; Sunell JE; Juva K
    Nord Med; 1971 Mar; 85(12):362-8. PubMed ID: 5574957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Laaksonen AL; Koskiahde V; Juva K
    Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimalarials in the treatment of rheumatoid arthritis.
    Zvaifler NJ
    Mod Treat; 1971 Nov; 8(4):769-77. PubMed ID: 4258497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ocular complications after treatment with antimalarial agents in dermatology].
    Mikkelsen J
    Ugeskr Laeger; 1979 Aug; 141(34):2316-8. PubMed ID: 315126
    [No Abstract]   [Full Text] [Related]  

  • 6. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 7. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind evaluation of the therapeutic efficacy of D-penicillamine and hydroxychloroquine in juvenile rheumatoid arthritis].
    Kuz'mina NN; Briuér EI; Isaeva LA; Alekseev LS; Shokh BP
    Revmatologiia (Mosk); 1987; (1):7-12. PubMed ID: 3299632
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxychloroquine does not decrease serum methotrexate concentrations in children with juvenile idiopathic arthritis.
    Haapasaari J; Kautiainen H; Isomäki H; Hakala M
    Arthritis Rheum; 2005 May; 52(5):1621-2. PubMed ID: 15880808
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study.
    Lomater G; Gattinara M; Gerloni V; Zeni S; Fantini F
    Acta Univ Carol Med (Praha); 1994; 40(1-4):109-12. PubMed ID: 9355684
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The therapy of systemic lupus erythematosus].
    Ochsendorf FR; Runne U
    Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chloroquine retinopathy: avoidable by individualized daily dosing].
    Ochsendorf FR; Runne U; Goerz G; Zrenner E
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of juvenile rheumatoid arthritis by antimalarial drugs. Dosage in syrup and tablets.
    Laaksonen AL; Sunell JE; Juva K
    Acta Paediatr Scand Suppl; 1970; 206():Suppl 206:119. PubMed ID: 5276937
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis.
    Ravelli A; Di Fuccia G; Molinaro M; Ramenghi B; Zonta L; Regazzi MB; Martini A
    J Rheumatol; 1993 Sep; 20(9):1573-7. PubMed ID: 8164218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB
    J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose relationships in patients with early chloroquine retinopathy.
    Easterbrook M
    J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs].
    Ochsendorf FR; Runne U
    Hautarzt; 1991 Mar; 42(3):140-6. PubMed ID: 2055762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ophthalmic side effects of chloroquine in patients with rheumatoid arthritis].
    Sarmela T; Kajander A
    Duodecim; 1968; 84(5):306-11. PubMed ID: 5670747
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can indomethacin prolong arthritis?].
    Savolainen A; Isomäki H
    Duodecim; 1995; 111(3):257-9. PubMed ID: 8654290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.